Kitasato Research Institute

The Kitasato Institute is a premier Japanese private research and educational organization specializing in the life sciences, medicine, and infectious diseases. Founded in 1914 by Dr. Shibasaburo Kitasato, the institute has a distinguished history of scientific breakthroughs, most notably the discovery of avermectins which earned Dr. Satoshi Ōmura the 2015 Nobel Prize in Physiology or Medicine. The organization operates Kitasato University and several affiliated hospitals, integrating basic research with clinical practice and education. Its research activities focus heavily on drug discovery from natural products, vaccine development, and the study of microbial chemistry. Through strategic partnerships with global pharmaceutical leaders like Merck & Co., the Kitasato Institute continues to translate its academic findings into impactful therapeutic solutions for global health challenges. It remains a cornerstone of Japan's biotechnology landscape, contributing significantly to both public health and scientific education.